CC
BGMS

Commodore Capital’s Bio Green Med Solution Inc BGMS Stock Holding History

Commodore Capital’s Portfolio BGMS Stock Details BGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-74
Closed -$2.07M – 32
2020
Q4 		$2.07M Buy
+74
New +$1.13M 1.12% 26

Other funds holding BGMS

SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Commodore Capital's BGMS Position: Q1 2021 in Review

Commodore Capital sold out of Bio Green Med Solution Inc (BGMS) in Q1 2021, closing a stake of 74 shares — an estimated $2.07M sold.

Commodore Capital first reported a position in BGMS in Q4 2020 and held it in 1 quarter. The position peaked at $2.07M in Q4 2020. 29 funds tracked by Wall St. Rank hold BGMS as of Q1 2021.

  • Commodore Capital reported no remaining Bio Green Med Solution Inc position as of Q1 2021 after selling out during the quarter.
  • Commodore Capital sold 74 Bio Green Med Solution Inc shares in Q1 2021, an estimated $2.07M.
  • Commodore Capital first reported a position in Bio Green Med Solution Inc in Q4 2020 and held it in 1 quarter.
  • Commodore Capital's Bio Green Med Solution Inc position peaked at $2.07M in Q4 2020.
  • 29 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q1 2021.

Based on Commodore Capital's 13F filing for Q1 2021, filed 17 May 2021.